Photo of Richard Burr
R United States Senate · North Carolina

Sen. Richard Burr

Compare
Total votes
380
all sessions
Attendance
87%
49 missed
Among the lowest in the chamber
With party
87%
of cast votes
Lower than 88% of chamber peers
Bipartisan score
7%
crosses aisle rarely
Higher than 87% of chamber peers
Sponsored
203
bills & resolutions
Lower than 94% of chamber peers
Committees
0
assignments
203 bills and resolutions

Sponsored bills

Total
203
Primary
23
Co-sponsor
180
This page
203
matching current filters
Primary S 4568
In committee Jul 20, 2022 0 co-sponsors
Primary S 4535
In committee · United States Senate · Lead sponsor
FDASRA Act of 2022

Food and Drug Administration Simple Reauthorization Act of 2022 or the FDASRA Act of 2022 This bill reauthorizes the authority of the Food and Drug Administration to collect certain fees related to drugs, medical devices, and biosimilar biological products and modifies such fees, including the base fee amounts.

In committee Jul 14, 2022 0 co-sponsors
Co-sponsor S 4348
In committee · United States Senate · Co-sponsor
FDASLA Act of 2022

Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 This bill modifies Food and Drug Administration (FDA) authority to collect certain fees. It also expands FDA authority to regulate certain products, including cosmetics. Among other provisions, the bill reauthorizes FDA authority to collect certain fees related to drugs, medical devices, and biosimilar biological products and modifies such fees, including the base fee amounts; establishes that certain requirements related to obtaining market approval for a new drug or a biosimilar may be satisfied using alternatives to animal testing, such as in vitro tests; authorizes the FDA to require that certain drugs be dispensed with a safe disposal system even if the system does not render a drug nonretrievable (current law requires such a system to render the drug nonretrievable); establishes time lines for the FDA to respond to requests to determine whether a drug is a therapeutic equivalent to an approved drug; modifies the accelerated process for approving products for a serious or life-threatening disease or condition and establishes an intra-agency coordinating council to ensure consistent and appropriate use of the process; requires additional regulation of cosmetics, including by requiring manufacturers to register manufacturing facilities and each cosmetic product with the FDA; requires dietary supplement manufacturers to provide to the FDA certain information, including a list of all ingredients, about each dietary supplement that it markets; requires an in vitro clinical test to receive FDA premarket approval or a technology certification (or be otherwise exempted) before being introduced into interstate commerce; and requires the FDA to temporarily relax certain premarket requirements for a manufacturer that intends to market a new infant formula.

In committee Jul 13, 2022 1 co-sponsor
Co-sponsor SRES 676
Passed · United States Senate · Co-sponsor
A resolution expressing support for the designation of June 23, 2022, as "National Pell Grant Day".

This resolution celebrates the 50th anniversary of the Federal Pell Grant program and expresses support for the designation of June 23 as National Pell Grant Day.

Passed Jun 23, 2022 1 co-sponsor
Co-sponsor SRES 690
Passed · United States Senate · Co-sponsor
A resolution designating July 8, 2022, as "Collector Car Appreciation Day" and recognizing that the collection and restoration of historic and classic cars is an important part of preserving the technological achievements and cultural heritage of the United States.

This resolution (1) supports the designation of July 8, 2022, as Collector Car Appreciation Day, (2) recognizes the collection and restoration of historic and classic cars as an important part of preserving the technological achievements and cultural heritage of the United States, and (3) encourages engagement in Collector Car Appreciation Day events.

Passed Jun 22, 2022 1 co-sponsor
Primary S 4449
In committee · United States Senate · Lead sponsor
Saving Access to Laboratory Services Act

Saving Access to Laboratory Services Act This bill modifies provisions relating to Medicare payment rates for clinical diagnostic laboratory services, including by requiring payment rates for certain widely available clinical diagnostic laboratory tests to be based on a statistical sampling of private sector rates.

In committee Jun 22, 2022 0 co-sponsors
Co-sponsor S 4431
Introduced · United States Senate · Co-sponsor
Pregnant Workers Fairness Act

Pregnant Workers Fairness Act This bill prohibits employment practices that discriminate against making reasonable accommodations for qualified employees affected by pregnancy, childbirth, or related medical conditions. A qualified employee is an employee or applicant who, with or without reasonable accommodation, can perform the essential functions of the position, with specified exceptions. Specifically, the bill declares that it is an unlawful employment practice to fail to make reasonable accommodations to known limitations of such employees unless the accommodation would impose an undue hardship on an entity's business operation; require a qualified employee affected by such condition to accept an accommodation other than any reasonable accommodation arrived at through an interactive process; deny employment opportunities based on the need of the entity to make such reasonable accommodations to a qualified employee; require such employees to take paid or unpaid leave if another reasonable accommodation can be provided; or take adverse action in terms, conditions, or privileges of employment against a qualified employee requesting or using such reasonable accommodations. The bill sets forth enforcement procedures and remedies that cover different types of employees in relation to such unlawful employment practices. The Equal Employment Opportunity Commission must provide examples of reasonable accommodations that shall be provided to affected employees unless the employer can demonstrate that doing so would impose an undue hardship. The bill prohibits state immunity under the Eleventh Amendment to the Constitution from an action for a violation of this bill.

Introduced Jun 21, 2022 1 co-sponsor
Co-sponsor S 4353
In committee · United States Senate · Co-sponsor
RISE & SHINE Act

Retirement Improvement and Savings Enhancement to Supplement Healthy Investments for the Nest Egg Act or the RISE & SHINE Act This bill makes various changes with respect to employer-sponsored retirement plans. For example, the bill allows plans sponsored by charities, educational institutions, and nonprofit organizations (i.e., 403(b) retirement plans) to participate in multiple employer plans and pooled employer plans. The bill also revises the notice and disclosure requirements for certain retirement plans, and it permits plan sponsors to make emergency savings accounts available to participants of defined contribution plans.

In committee Jun 21, 2022 1 co-sponsor
Co-sponsor S 4416
In committee · United States Senate · Co-sponsor
Educational Choice for Children Act

Educational Choice for Children Act This bill allows individuals and corporations a new tax credit after 2022 for charitable contributions to tax-exempt organizations that provide scholarships to elementary and secondary school students. Such students must be members of a household with incomes not greater 300% of the area median gross income and be eligible to enroll in a public elementary or secondary school. The bill excludes from the gross income of taxpayer dependents any scholarship amount for the elementary or secondary education expenses of eligible students. It also prohibits governmental control over scholarship granting organizations.

In committee Jun 16, 2022 1 co-sponsor
Showing 31 to 40 of 203 bills
Previous 1 … 3 4 5 … 21 Next